Taiwan FDA registration 206b00aa43c89bb59d9c23dba68874b7
"Abe" insulin injection pen needle (general type)
TW: “安倍” 胰島素注射筆專用針(一般型)
Taiwan·Risk Class 2·PROMISEMED HANGZHOU MEDITECH CO., LTD.·Registered Mar 30, 2023 – Mar 30, 2028ActiveRegistration details
- Analysis ID
- 206b00aa43c89bb59d9c23dba68874b7
- Customs Code
- DHA09200143701
Company information
- Manufacturer
- PROMISEMED HANGZHOU MEDITECH CO., LTD.
- Manufacturer Country
- China
- Authorized Representative
- WINE-FONT INTERNATIONAL COMMERCE CORP.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5570 Subcutaneous single-chamber needle
- Import Information
- Input;; Chinese goods
Dates and status
- Registration Date
- Mar 30, 2023
- Expiry Date
- Mar 30, 2028
About this record
Access comprehensive regulatory information for "Abe" insulin injection pen needle (general type) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 206b00aa43c89bb59d9c23dba68874b7 and manufactured by PROMISEMED HANGZHOU MEDITECH CO., LTD.. The authorized representative in Taiwan is WINE-FONT INTERNATIONAL COMMERCE CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices